Comparative Metabolomics Reveals Endogenous Ligands of DAF-12, a Nuclear Hormone Receptor, Regulating C. elegans Development and Lifespan  by Mahanti, Parag et al.
Cell Metabolism
ArticleComparative Metabolomics Reveals Endogenous
Ligands of DAF-12, a Nuclear Hormone Receptor,
Regulating C. elegans Development and Lifespan
Parag Mahanti,1,6 Neelanjan Bose,1,6 Axel Bethke,1 Joshua C. Judkins,1 Joshua Wollam,2 Kathleen J. Dumas,3
Anna M. Zimmerman,1 Sydney L. Campbell,1 Patrick J. Hu,3,4 Adam Antebi,2,5 and Frank C. Schroeder1,*
1Boyce Thompson Institute and Department of Chemistry and Chemical Biology, Cornell University, Ithaca, NY 14853, USA
2Max Planck Institute for Biology of Ageing, Joseph Stelzmann Strasse 9b, 50931 Cologne, Germany
3Life Sciences Institute, University of Michigan, Ann Arbor, MI 48109, USA
4Departments of Internal Medicine and Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, MI 48109, USA
5Huffington Center on Aging, Department of Molecular and Cellular Biology, Baylor College of Medicine, One Baylor Plaza, Houston,
TX 77030, USA
6These authors contributed equally to this work
*Correspondence: schroeder@cornell.edu
http://dx.doi.org/10.1016/j.cmet.2013.11.024SUMMARY
Small-molecule ligands of nuclear hormone recep-
tors (NHRs) govern the transcriptional regulation
of metazoan development, cell differentiation, and
metabolism. However, the physiological ligands of
many NHRs remain poorly characterized, primarily
due to lack of robust analytical techniques. Using
comparative metabolomics, we identified endoge-
nous steroids that act as ligands of the C. elegans
NHR, DAF-12, a vitamin D and liver X receptor homo-
log regulating larval development, fat metabolism,
and lifespan. The identified molecules feature unex-
pected chemical modifications and include only one
of two DAF-12 ligands reported earlier, necessitating
a revision of previously proposed ligand biosynthetic
pathways. We further show that ligand profiles are
regulatedby a complex enzymatic network, including
the Rieske oxygenase DAF-36, the short-chain
dehydrogenase DHS-16, and the hydroxysteroid
dehydrogenase HSD-1. Our results demonstrate the
advantages of comparativemetabolomics over tradi-
tional candidate-based approaches and provide a
blueprint for the identification of ligands for other
C. elegans and mammalian NHRs.
INTRODUCTION
Small-molecule ligands of nuclear hormone receptors (NHRs), a
conserved family of ligand-activated transcription factors, con-
trol diverse aspects of metabolism, cell differentiation, develop-
ment, and aging. Precise knowledge of ligand structures and
biosynthetic pathways is essential for understanding NHR
function (Mangelsdorf et al., 1995; Wollam and Antebi, 2011)
because even small differences in ligand structures may result
in dramatic changes of transcriptional activity and specificityC(Brown and Slatopolsky, 2008; Singarapu et al., 2011). However,
the endogenous ligands of many NHRs remain poorly character-
ized, in part because ligands constitute very minor components
of highly complex animal metabolomes (Schupp and Lazar,
2010). The free-living nematode C. elegans has 284 NHRs,
allows facile genetic manipulation, and can be grown in large
quantities, providing an opportunity to investigate structures,
biosynthesis, and functions of NHR ligands in a relatively simple
model system (Taubert et al., 2011). Although many of the 284
C. elegans NHRs appear to be derived from extensive duplica-
tion and diversification of an ancestral gene related to mamma-
lian hepatocyte nuclear factor 4 (HNF4) receptors and may not
be ligand regulated, several C. elegans NHRs represent ortho-
logs of hormone-regulated NHRs in other metazoans (Antebi,
2006; Palanker et al., 2009; Taubert et al., 2011). Themost prom-
inent C. elegans NHR, DAF-12, a homolog of vertebrate vitamin
D and liver X receptors (VDR and LXR, respectively), functions as
a ligand-dependent switch that regulates both adult lifespan and
larval development (Antebi et al., 2000; Fielenbach and Antebi,
2008; Kenyon, 2010; Riddle et al., 1981; Riddle and Albert,
1997; Shen et al., 2012). The biosynthesis of the steroidal ligands
of DAF-12 is controlled by a complex endocrine signaling
network, of which many components appear to be conserved
between C. elegans and mammals (Fielenbach and Antebi,
2008). Perception of environmental stimuli by chemosensory
neurons modulates conserved insulin/IGF and transforming
growth factor b (TGF-b) signaling pathways, which converge
on genes implicated in DAF-12 ligand biosynthesis (Figure 1A).
Under unfavorable conditions, such as overcrowding or scarcity
of food, ligand biosynthesis is suppressed, and unliganded DAF-
12 interacts with its corepressor DIN-1 (Ludewig et al., 2004).
The resulting repression of DAF-12 target genes causes devel-
opmental arrest and entry into a highly stress-resistant larval
stage called the dauer diapause (Gems et al., 1998; Hu, 2007;
Larsen et al., 1995; Schaedel et al., 2012). In contrast, favorable
conditions trigger upregulation of DAF-12 ligand biosynthesis.
DAF-12 ligand binding then results in dissociation of the core-
pressor DIN-1 to allow expression of DAF-12 target genes, pro-
moting rapid development from larvae to reproductive adultsell Metabolism 19, 73–83, January 7, 2014 ª2014 Elsevier Inc. 73
Figure 1. Steroidal Ligands Control C. elegans Development and
Lifespan via the Nuclear Hormone Receptor DAF-12
(A) Under favorable conditions, insulin/IGF and TGF-b signaling drive biosyn-
thesis of steroidal DAF-12 ligands. Liganded DAF-12 promotes development,
in part via transcription of the let-7 family microRNAs mir-84 and mir-241.
Under unfavorable conditions, ligand biosynthesis is inhibited, resulting in
interaction of unliganded DAF-12 with its corepressor DIN-1.
(B) Previously described DAF-12 ligands and proposed biosynthetic path-
ways. DAF-12 ligand biosynthesis is downregulated in response to dauer
pheromone, a blend of ascarosides (e.g., the shown ascr#2; red).
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ligand-dependent activation of the DAF-12 target genes mir-84
and mir-241, two microRNAs of the conserved let-7 family
(Bethke et al., 2009; Hammell et al., 2009), is required for lifespan
regulation in response to signals from reproductive tissues (Shen
et al., 2012; Yamawaki et al., 2010). These findings indicate that
metazoan lifespan is coupled to the gonad via NHR signaling.
Based on extensive biochemical studies, two bile acid-like
steroids named D4- and D7-dafachronic acid (DA) were pro-
posed as endogenous ligands of DAF-12 (Figure 1B) (Motola
et al., 2006). Identification of the DAs as DAF-12 ligand candi-
dates was based on precursor studies in which a variety of
3-keto sterols were identified as substrates for the cytochrome
P450, DAF-9, which had been shown to act upstream of DAF-
12 in DAF-12 ligand biosynthesis (Gerisch et al., 2001; Jia
et al., 2002; Motola et al., 2006). DAF-9 was further shown to
act on the side chain in these steroids, introducing a terminal
carboxyl group (Motola et al., 2006). In a separate study, a
DAF-12-activating isomer of 3b-hydroxy-5-cholestenoic acid74 Cell Metabolism 19, 73–83, January 7, 2014 ª2014 Elsevier Inc.was detected in C. elegans metabolite extracts (Held et al.,
2006). However, given the very low concentrations of the puta-
tive DAF-12 ligands in C. elegans, isolation and full spectro-
scopic characterization of these compounds was not pursued.
Although none of the structures of the proposed DAF-12
ligands have been confirmed based on conclusive spectro-
scopic analysis of C. elegans-derived samples, a biosynthesis
model has been developed (Figure 1B), and the biochemical
roles of genes proposed to function upstream of DAF-9 in
DAF-12 ligand biosynthesis have been studied extensively
(Dumas et al., 2010; Gerisch et al., 2007; Patel et al., 2008; Rot-
tiers et al., 2006; Williams et al., 2010; Wollam et al., 2011; Yosh-
iyama-Yanagawa et al., 2011). More recent work has shown that
the proposed DAF-12 ligands do not explain all DAF-12-associ-
ated functions and suggested the possibility that other DAs may
exist (Patel et al., 2008;Williams et al., 2010;Wollam et al., 2012).
In this study, we identify the endogenous ligands of DAF-12
using an unbiased comparative metabolomics approach (For-
seth and Schroeder, 2011), which revealed ligand structures
and differential regulation of DAF-12 ligand biosynthesis.
RESULTS
Customizing a Comparative Metabolomics Approach
We aimed to identify endogenous DAF-12 ligands from direct
spectroscopic evidence, in contrast to earlier work that
relied on classical genetics and biochemical experiments. For
this purpose, we combined activity-guided fractionation and
NMR-based comparative metabolomics via DANS (differential
analyses by 2D NMR spectroscopy) (Figure 2A). 2D NMR spec-
troscopy can provide a largely unbiased overview of metabo-
lome composition, and comparing 2D NMR spectra of different
mutant backgrounds via DANS often permits detection and
partial identification of minor metabolites such as signaling
molecules (Forseth and Schroeder, 2011; Pungaliya et al.,
2009). DANS relies on correlating genetic changes with metab-
olomic changes for compound identification, thereby reducing
the need for extensive fractionation, which can result in activity
loss or the introduction of artifacts. We envisioned that this
strategy could be applied to identify DAF-12 ligands if one
compared a mutant metabolome lacking DAF-12 ligands with
the metabolome of worms that produce DAF-12 ligands
abundantly.
For DANS-based ligand identification, we chose daf-9;daf-12
doublemutants as the ligand-deficient strain and daf-22mutants
as a putatively ligand-rich reference strain. daf-9;daf-12 double
mutants do not produce DAF-12 ligands, but nonetheless
bypass the dauer stage, because lack of DAF-12 prevents the
execution of genetic programs required for dauer formation
(Gerisch and Antebi, 2004). Therefore, these animals can be
grown in quantities large enough for NMR spectroscopic ana-
lyses. daf-22 mutant worms develop normally to adulthood but
are defective in the biosynthesis of the dauer-inducing ascaro-
sides (Butcher et al., 2009; von Reuss et al., 2012), which we
hypothesized may adversely affect DAF-12 ligand production
in wild-type (WT) liquid cultures (Figure 1B). Downregulation of
DAF-12 ligand biosynthesis by ascarosides is also suggested
by the finding that exposure to high concentrations of dauer
pheromone abolished expression of DAF-9, one of the key
Figure 2. Detection of DAF-12 Ligands in C. elegans Mutant Metabolomes
(A) Fractionation of active, ligand-rich daf-22 and inactive daf-9;daf-12 metabolomes is followed by 2D NMR-based comparative metabolomics of active
fractions.
(B) Assessment of DAF-12 ligand content using (1) an in vitro luciferase assay in HEK293T cells transfected with full-length DAF-12 and a mir84p-luciferase
reporter vector and (2) in vivo daf-9(dh6) dauer rescue assays.
(C) daf-9;daf-12 metabolome fractions are inactive in the luciferase assay. We used 100 nM D7-DA as a positive control (error bars, ± SD).
(D) Luciferase assays of daf-22 metabolome fractions reveal three active regions (error bars, ± SD).
(E) daf-9(dh6) dauer rescue assays of daf-22 metabolome fractions show activity in the same three regions (error bars, ± SD). For worm images of scored
phenotypes, see Figure S1C. See also Figure S1.
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ligands (Schaedel et al., 2012). Furthermore, given that the
mammalian ortholog of DAF-22, SCPx, is involved in oxidative
breakdown of steroid side chains in bile acid biosynthesis, it
seemed possible that DAF-22 contributes to degradation of
steroidal DAF-12 ligands in C. elegans.
To prepare for DANS analysis, metabolome extracts of daf-9;
daf-12, WT, and daf-22 mixed-stage liquid cultures were
fractionated using an automated, highly reproducible chroma-
tography system (Figure 2A and Supplemental Experimental
Procedures). The resulting parallel sets of metabolome fractions
were assessed for DAF-12 ligand content using in vivo and
in vitro bioassays (Figure 2B). The in vivo assay used daf-
9(dh6) worms, which are defective in DAF-12 ligand production.
In the absence of exogenously added DAF-12 ligand or a suit-
able precursor, developing daf-9(dh6) worms arrest as dauer
larvae because unliganded DAF-12 constitutively interacts with
its corepressor DIN-1 (Gerisch et al., 2007; Ludewig et al.,
2004). The assay scored the ability of added fractions to rescueCthe arrested dauer larvae and promote development to adult-
hood, providing a measure for the presence of a DAF-12 ligand
that would dissociate the DAF-12/DIN-1 complex. The in vitro
assay measured transcriptional activation by DAF-12 of a lucif-
erase reporter in human embryonic kidney 293T (HEK293T) cells
that were cotransfected with full-length DAF-12 and the reporter
construct (Bethke et al., 2009). This assay provided a measure
for ligand-dependent interaction of DAF-12 with mammalian
coactivator(s) in the cells. Both of these assays consistently
showed activity for three groups of daf-22 and WT fractions
(regions I–III in Figures 2C–2E; for WT assay data, see Figure S1
available online), indicating the presence of DAF-12 ligands or
precursors, whereas all daf-9;daf-12 fractions were inactive in
both assays, in accordance with previous work (Gerisch and
Antebi, 2004; Gerisch et al., 2007; Motola et al., 2006). As antic-
ipated, daf-22 fractions were significantly more active in the
daf-9(dh6) dauer rescue assay compared to the corresponding
WT fractions, suggesting higher production of DAF-12 ligands
in daf-22 mutants (Figure S1).ell Metabolism 19, 73–83, January 7, 2014 ª2014 Elsevier Inc. 75
Figure 3. Detection and Identification of Endogenous DAF-12 Ligand Candidates via 2D NMR-Based Comparative Metabolomics and SIM
GC-MS
(A) DQF-COSY spectrum of inactive daf-9;daf-12metabolome fraction corresponding to active region I (Figures 2C–2E). Enlarged section (upper left) compares
daf-9;daf-12 with the corresponding section of the daf-22 spectrum, showing one of the differential cross-peaks (red) that led to identification of D1,7-DA, next to
nondifferential signals representing a metabolite present in both daf-9;daf-12 and daf-22, an epidioxy sterol (blue). Enlarged section (lower right) shows example
cross-peaks from the comparison of the spectra of strm-1 (vide infra) and daf-9;daf-12 metabolomes, showing signals (green) characteristic for D7-DA in the
strm-1 spectrum, but not the daf-9;daf-12 spectrum.
(B) SIMGC-MS of active daf-22metabolome fraction indicating the presence ofD1,7-DA. The additional peak at29.4min in the ion tracem/z = 426 belongs to an
unrelated compound.
(C) SIM GC-MS of synthetic D1,7-DA confirms retention times and fragmentation patterns.
(D) Major electron ionization-mass spectrometry (EI-MS) fragments of D1,7-DA used in Figures 3B and 3C. See also Figure S2. For NMR spectroscopic data,
see Tables S1 and S2.
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Features
2D NMR spectra of the most active group of daf-22 fractions,
active region I, revealed long-chained ascarosides (Pungaliya
et al., 2009) in addition to a complex mixture of fatty acids, glyc-
erides, other lipids, and epidioxy sterol derivatives (Figures 3A
and S2A), all of which were also present in similar concentrations
in corresponding daf-9;daf-12 fractions. Closer inspection of re-
gion I 2D NMR spectra revealed several sets of signals that were
consistently absent in daf-9;daf-12 and thus appeared to be daf-
9 dependent (Figure 3A). Further analysis of these differential sig-
nals suggested that they represent steroidal structures. Because
of their very low concentrations, identification of the putative daf-
9-dependent steroids required additional fractionation via high-
performance liquid chromatography (HPLC), which resulted in
two active samples, each containing 1%–2% of daf-9-depen-
dent components (Figures S2B and S2C). NMR spectroscopic
analysis of the most active fractions showed a distinct set of
daf-9-dependent signals at 5.9 and 7.0 ppm with a coupling
constant of 10 Hz, which indicated the presence of an unusual
D1-unsaturated 3-ketosteroid (Figure 3A). Comparison with pub-
lished data suggested the presence of 3-oxo-1,7-cholestadie-76 Cell Metabolism 19, 73–83, January 7, 2014 ª2014 Elsevier Inc.noic acid (D1,7-DA), which had not previously been described
from worms, in addition to smaller amounts of the known
D7-DA (Figures 3A and 4A) (Motola et al., 2006). These assign-
ments were confirmed by comparison of spectroscopic data
and gas chromatography-mass spectrometry (GC-MS) retention
times with those of synthetic samples of D1,7-DA and D7-DA
(Figures 3B, 3C, and S2D–S2I). To determine the relative config-
uration of the chiral centers at position 25 in the side chains of
D7-DA and D1,7-DA, we compared the NMR spectra of synthetic
samples of (25S)- and (25R)-diastereomers with those of the
natural samples. These analyses established the configuration
of natural D7-DA and D1,7-DA as (25S) (Figure 4). D1-unsaturated
steroids are rare in nature, and we are aware of only one other
example in animals (Wang et al., 2009a).
Comparative analysis of active region II led to the identifica-
tion of another daf-9-dependent cholestenoic acid derivative,
featuring unusual 3a-hydroxylation: (25S)-3a-hydroxy-7-choles-
tenoic acid (3a-OH-D7-DA) (Figures 4A and S2J–S2O). The
GC-MS fragmentation pattern of 3a-OH-D7-DA suggests that it
is identical to the unidentified isomer of (25S)-3b-cholestenoic
acid previously reported as a DAF-12 ligand by Held et al.
(2006) (Figure S2K). As all 3-hydroxylated steroids previously
Figure 4. Structures and 1H-NMR-Based Assignment of Absolute
Configuration of DAF-12 Ligands
(A) Structures of D1,7-DA (dafa#1), D7-DA (dafa#2), 3a-OH-D7-DA (dafa#3),
D4-DA (dafa#4),D0-DA (dafa#5), and 3b-OH-D7-DA (dafa#6). See Experimental
Procedures for compound nomenclature.
(B) NMR spectroscopic determination of the relative configuration at C-25 in
naturalD7-DA. C-18 singlet region of 1HNMRspectra (600MHz, pyridine-d5) of
natural D7-DA and mixtures with synthetic (25R)-D7-DA and (25S)-D7-DA.
(C) NMR spectroscopic determination of the relative configuration at C-25 in
natural D1,7-DA. C-18 singlet region of 1H NMR spectra (600 MHz, pyridine-d5)
of natural D1,7-DA and mixtures with synthetic (25R)-D1,7-DA and synthetic
(25S)-D1,7-DA.
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cation of 3a-OH-D7-DA was surprising. We then inspected both
active and inactive C. elegans metabolome fractions for the
presence of the corresponding 3b stereoisomer, 3b-OH-D7-DA
(Figure 4A); however, 3b-OH-D7-DA could not be detected in
either WT or daf-22 metabolomes, indicating that production of
3a-OH-D7-DA is highly selective. Active region III, representing
a series of metabolome fractions with weak daf-9(dh6) dauer
rescue activity, revealed trace quantities of glucosides of DAs
that were not characterized further.
D1,7-DA and D7-DA Are Potent DAF-12 Ligands
Next, we investigated the biological properties of synthetic
samples of the identified daf-9-dependent steroids (Figures
5A–5D). Synthetic D1,7-DA activated DAF-12 in mammalian cells
(half-maximal effective concentration [EC50] = 146 nM), and
its potency in the daf-9(dh6) dauer rescue assay was similarC(EC50 = 2 nM) or slightly higher than that of D
7-DA (Figure 5B
and Table S3). Similarly, 3a-OH-D7-DA was active in both the
in vivo and in vitro assays, whereas its 3b-stereoisomer did not
activate DAF-12 in mammalian cells at any tested concentration
and rescued the daf-9(dh6) dauer phenotype only at very high
concentrations (Figure 5B). We also assayed the twomost abun-
dant daf-9-dependent compounds for their effect on lifespan in
germline-deficient glp-1 mutant worms. Germline-deficient glp-
1mutant worms live up to 60% longer than WT, and this lifespan
extension has been shown to depend on functional DAF-12 and
DAF-12 ligand biosynthetic enzymes (Gerisch et al., 2001; Hsin
and Kenyon, 1999; Yamawaki et al., 2010). Correspondingly,
ligand-deficient glp-1;daf-36 double-mutant worms lack the
glp-1 lifespan phenotype (Gerisch et al., 2007; Rottiers et al.,
2006). We found that both D7-DA and D1,7-DA fully restore glp-
1-dependent lifespan extension to glp-1;daf-36 worms (Figures
5C and S3A).
For quantification of the identified daf-9-dependent steroids,
we employed selective ion monitoring (SIM) GC-MS detection
of characteristic MS fragments of volatile methylated or silylated
derivatives (Supplemental Experimental Procedures). SIM
GC-MS showed that D1,7-DA is slightly more abundant than
D7-DA in daf-22 worms, whereas in WT animals, D1,7-DA is
more than twice as abundant as D7-DA, with concentrations
(averaged over the worm bodies) of 93 nM and 197 nM for
D7-DA and D1,7-DA, respectively (Figure 5E). 3a-OH-D7-DA
occurs at concentrations about 3- to 5-fold lower than those
of D7-DA in both WT and daf-22 mutants. Based on the specific
activities determined for synthetic samples of D7-DA, D1,7-DA,
and 3a-OH-D7-DA, it appears that these three compounds
account for all of the activity in regions I and II in both the WT
and daf-22 metabolomes. Using SIM GC-MS, we also checked
the daf-22 and WT metabolomes for the presence of the previ-
ously reported D4-DA. We were unable to detect D4-DA in any of
our C. elegans metabolome fractions, whereas fractions spiked
with trace quantities of synthetic D4-DA confirmed the sensi-
tivity of our detection methods (Figure S2P). We then consid-
ered that our growth conditions may have affected production
of the putative precursor of D4-DA, 4-cholesten-3-one (Motola
et al., 2006; Patel et al., 2008). However, analysis of WT metab-
olome samples by GC-MS and NMR spectroscopy revealed
that 4-cholesten-3-one is as abundant as lathosterone (Figures
S2Q–S2V), a putative precursor of D7-DA (Motola et al., 2006;
Wollam et al., 2012), suggesting that absence of D4-DA is not
the result of a lack of suitable precursors. Therefore, it appears
that D4-DA may not play a significant role as a DAF-12 ligand,
although its transient or very-low-level production cannot be
excluded.
To test whether the identified daf-9-dependent compounds
constitute bona fide ligands of DAF-12, we measured ligand-
dependentbindingofDAF-12with theSRC1-4peptidecontaining
thenuclear receptorbox (NRbox)motif ofmammaliancoactivator
SRC-1 (Heery et al., 1997). We found that D7-DA, D1,7-DA,
and 3a-OH-D7-DA affect concentration-dependent recruitment
of SRC1-4, with EC50 values of 8 nM and 15 nM for D
7-DA
and D1,7-DA, respectively, whereas affinity of 3a-OH-D7-DA was
lower (EC50 = 200 nM, Figure 5D and Table S3). These relative
potencies of D7-DA, D1,7-DA, and 3a-OH-D7-DA are similar to
relative activities observed in the luciferase assay (Figure 5A).ell Metabolism 19, 73–83, January 7, 2014 ª2014 Elsevier Inc. 77
Figure 5. Biological Activities of DAF-12 Ligands and Quantification of DAF-12 Ligands in C. elegans WT, Steroid Metabolism Mutant, and
daf-12(0) Mutant Worms
(A) DAF-12 transcriptional activation in HEK293T cells by the identified endogenous DAF-12 ligand candidates. Luciferase assays were measured in triplicates
(error bars, ± SD).
(B) daf-9(dh6) dauer rescue with the identified endogenous DAF-12 ligand candidates at 27C. For each data point, there were two replicates with 100 animals per
replicate (error bars, ± SD).
(C) Both D7-DA (100 nM) and D1,7-DA (100 nM) restore lifespan extension to glp-1 animals in daf-36 null mutant background.
(D) AlphaScreen assay for ligand-dependent recruitment of SRC1-4 peptide by DAF-12, showing fold activation of DAF-12 with different ligand candidates over
ethanol control (error bars, SEM).
(E) In vivo concentrations of the identified endogenous dafachronic acids in WT (N2), daf-22, daf-12, and steroid metabolism mutants (error bars, ± SD) grown in
mixed-stage liquid cultures, as determined from SIM GC-MS analysis of metabolome fractions (for distribution of life stages at the time of harvesting, see
Figure S3R). Detection limits for SIM GC-MS-based quantification of dafachronic acids in these experiments were around 2.5 nM. See also Figure S3.
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are high-affinity ligands of DAF-12 that promote reproductive
development and adult longevity, whereas 3a-OH-D7-DA is of
lower potency in promoting these phenotypes, and D4-DA may
not be present at physiologically relevant concentrations. There-
fore, previous hypotheses about DAF-12 ligand structures and
their biosynthetic pathways must be revised.
Comparative Metabolomics Suggests Tissue-Specific
Ligand Biosynthesis
Using our comparative metabolomics strategy, we reinvesti-
gated the roles of four additional enzymes that have been pro-
posed to participate in DAF-12 ligand biosynthesis. In a recent
model (Figure 1B), DAF-12 ligand biosynthesis begins with
oxidation of cholesterol by the Rieske-like oxygenase, DAF-36,
yielding 7-dehydrocholesterol (Wollam et al., 2011; Yoshiyama-
Yanagawa et al., 2011). 7-dehydrocholesterol is converted by
an unknown enzyme to lathosterol, which is oxidized to the
corresponding ketone, lathosterone, by the short-chain dehy-
drogenase DHS-16 (Wollam et al., 2012). Lathosterone is then
converted to D7-DA by DAF-9 (Gerisch et al., 2007; Motola
et al., 2006). In addition, a parallel pathway for the biosynthesis
of D4-DA, involving the putative hydroxysteroid dehydrogenase
HSD-1, has been proposed (Dumas et al., 2010; Patel et al.,
2008). However, recent evidence suggests that HSD-1 has no78 Cell Metabolism 19, 73–83, January 7, 2014 ª2014 Elsevier Inc.role in the production of the putative precursor of D4-DA, 4-cho-
lesten-3-one (Wollam et al., 2012), leaving its role in DAF-12
ligand biosynthesis undetermined. Therefore, we began our
biosynthetic analysis with profiling hsd-1 mutants and hsd-
1;daf-22 double mutants. Whereas hsd-1 fractions contained
only very small amounts of dauer rescuing activity, the activity
profile of hsd-1;daf-22 fractions was similar to that of daf-22 frac-
tions, consistent with the hypothesis that dauer pheromone
biosynthesis via DAF-22 downregulates DAF-12 ligand produc-
tion (Figure S3D). However, comparative 2D NMR analysis of
hsd-1;daf-22 region I revealed production of large quantities of
an additional steroid in hsd-1;daf-22worms that is not produced
in either daf-22 or daf-9;daf-12 mutants. Comparison with a
synthetic sample led to the identification of this hsd-1-specific
steroid as (25S)-3-keto-cholestanoic acid (D0-DA; Figures 4A
and S3G–S3K). This fully saturated DA derivative is active in
both the DAF-12 luciferase assay and the daf-9(dh6) dauer
rescue assay, although its activity is lower than that of D1,7-DA
and D7-DA (Figures 5A and 5B). D0-DA was absent in WT and
daf-22 metabolomes, as determined by NMR and SIM GC-MS.
Analysis of hsd-1;daf-22 activity region II revealed a second
hsd-1-specific steroid, 3b-OH-D7-DA (Figure S3L). In hsd-
1;daf-22 mutants, 3b-OH-D7-DA is as abundant as the 3a
isomer, whereas 3b-OH-D7-DA is absent in both WT and
daf-22 mutants. GC-MS analysis of hsd-1;daf-22 activity region
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are slightly reduced compared to daf-22 worms, whereby pro-
duction of D7-DA may be more strongly affected than that of
D1,7-DA (Figure 5E).
The identification of 3b-OH-D7-DA and D0-DA in hsd-1;daf-22
mutant worms suggests that HSD-1 may directly or indirectly
participate in the biosynthesis of D7-DA and possibly D1,7-DA.
HSD-1 has homology to mammalian 3b-hydroxysteroid dehy-
drogenases (Patel et al., 2008), which suggested its participation
in introducing the 3-keto functionality in D4-DA. The absence of
D4-DA and our identification of D0-DA as a shunt metabolite in
hsd-1;daf-22 mutants may indicate that the hsd-1 pathway
includes introduction of the 7,8-double bond in a saturated pre-
cursor (for example, cholestanol, 3b-OH-D0-DA, or D0-DA) by
an unknown enzyme or that HSD-1 itself has 7-dehydrogenase
activity. Notably, HSD-1 is expressed mainly in the neuron-like
XXX cells, which lack expression of the oxygenase DAF-36
required for biosynthesis of most 7,8-unsaturated steroids in
C. elegans (Wollam et al., 2011; Yoshiyama-Yanagawa et al.,
2011). Taken together, our results suggest that HSD-1 contrib-
utes to D7-DA biosynthesis in the XXX cells but that D7-DA and
D1,7-DA are produced via a separate pathway in other tissues.
Next, we investigated the DAF-12 ligand profile of mutants of
the Rieske oxygenase, DAF-36 (Figure 1B) (Wollam et al., 2011;
Yoshiyama-Yanagawa et al., 2011). Mutants of daf-36, which is
expressed primarily in the worm intestine, exhibit phenotypes
consistent with strongly reduced DAF-12 ligand biosynthesis,
such as a higher tendency to enter dauer (Rottiers et al., 2006).
As in the case of hsd-1 mutants, daf-36 mutant metabolome
fractions were largely inactive in the dauer rescue and luciferase
assays, whereas daf-36;daf-22 double mutants produced sig-
nificant dauer rescue activity in region I (Figure S3E). GC-MS
analysis revealed the presence of saturated D0-DA in this region
(FiguresS3M–S3O), whichwepreviously found only in hsd-1;daf-
22mutants. In contrast to hsd-1;daf-22mutants, D0-DA appears
to be responsible for all activity observed in daf-36;daf-22 region
I, and neither D7-DA nor D1,7-DA was detectable in this mutant.
Total DAF-12 ligand amounts were much lower in the daf-
36;daf-22 metabolome than in hsd-1;daf-22 (Figure 5E). These
results indicate that the intestinally expressed 7,8-dehydroge-
nase, DAF-36, is required for D7-DA and D1,7-DA biosynthesis,
whereasHSD-1 contributes to additional production ofD7-unsat-
urated DAs in the XXX cells. Thus, it appears that biosynthesis of
D7-DA and D1,7-DA relies on partially redundant and tissue-spe-
cific pathways.
Biosynthesis of Different Ligands Is Differentially
Regulated
Whereas the hsd-1 mutation did not significantly affect the rela-
tive abundance of D1,7-DA and D7-DA, mutations of two other
genes involved in DAF-12 ligand biosynthesis and regulation,
the short-chain dehydrogenase (dhs-16) (Wollam et al., 2012)
and the methyltransferase (strm-1) (Hannich et al., 2009),
showed strongly altered ligand ratios. Similar to what we
observed for daf-36 and hsd-1 single mutants, bioassays of
metabolome fractions from dhs-16 single mutants showed very
low activity, whereas dhs-16;daf-22 double-mutant fractions
showed levels of activity similar to those of daf-22 fractions
(Figure S3F). Chemical analysis of the dhs-16;daf-22 frac-Ctions revealed that production of D7-DA was greatly reduced
compared to daf-22 single mutants, whereas D1,7-DA levels
were only slightly reduced (Figures 1B and 5E). These results
indicate that D1,7-DA and D7-DA may be derived from partially
divergent biosynthetic pathways or that deletion of dhs-16 indi-
rectly affects regulation of the D1,7-DA:D7-DA ratio. Only trace
quantities of 3a-OH-D7-DA were detected in dhs-16;daf-22
worms, suggesting that production of both 3a-OH-D7-DA and
D7-DA are DHS-16 dependent (Figure 5E). Next, we character-
ized the DAF-12 ligand profile of strm-1 mutants (Figure S3F),
which had previously been shown to produce elevated levels
of DAF-12 ligands (Hannich et al., 2009). The methyltransferase
STRM-1 regulates DAF-12 ligand levels by converting choles-
terol-derived intermediates of ligand biosynthesis into 4-methyl-
ated steroids, thereby rendering them unsuitable as ligand
precursors (Hannich et al., 2009). NMR spectroscopy and SIM
GC-MS analyses revealed levels of D7-DA increased more
than 100-fold in strm-1 metabolomes, whereas D1,7-DA levels
increased only about 7-fold compared to WT (Figure 5E).
We also investigated the DAF-12 ligand profile of daf-12
null mutants, which previously had been shown to produce
increased dauer rescuing activity (Held et al., 2006). We found
that, compared to WT, daf-12 mutants produced amounts of
3a-OH-D7-DA roughly 6-fold higher, whereas amounts of D1,7-
DA and D7-DA were only slightly increased (Figure 5E). In addi-
tion, daf-12 mutants produce large quantities of 3b-OH-D7-DA,
whereas this compound could not be detected in WT. These
observations indicate that DAF-12 ligand biosynthesis is dysre-
gulated in daf-12 null mutants, possibly as a result of changes
in the expression levels of additional ligand biosynthetic (or cata-
bolic) enzymes.
Given that DAF-12 ligands regulate both larval development
and germline-dependent adult longevity, it seemed possible
that different life stages may produce different ligand profiles.
SIM GC-MS analysis of metabolite extract from synchronized
larvae at the L2 and L3 stages showed a D7-DA:D1,7-DA ratio of
about 1:1, whereas in worms at the L4 and young adult stages,
the ratio is shifted toward D1,7-DA (Figures S3P and S3Q). More
detailed analysis of the ligand profiles of different life stages and
under different environmental conditions will have to await devel-
opment of more sensitive detection techniques, especially for
the somewhat chemically unstable D1,7-DA. Taken together, our
results indicate that the biosynthesis of different DAF-12 ligands
is differentially regulated, in part via feedback through DAF-12.
DISCUSSION
Identification of the endogenous ligands of NHRs is central to un-
derstanding their role as transcriptional regulators in metazoans.
Screening of synthetic ligands of the vitamin D receptor and
other mammalian NHRs has demonstrated that even small
changes in ligand structures can strongly affect gene transcrip-
tion (Brown and Slatopolsky, 2008; Singarapu et al., 2011; Wol-
lam and Antebi, 2011). However, there are few approaches to
comprehensively identify the endogenous NHR ligands from
complex animal metabolomes, whose chemical annotations
remain largely incomplete. In this study, we demonstrate the
use of comparative metabolomics to identify the endogenous
ligands of DAF-12, a central regulator of development and adultell Metabolism 19, 73–83, January 7, 2014 ª2014 Elsevier Inc. 79
Figure 6. Comparison of NHR Signaling in Nematodes and Mammals and a Model for DAF-12 Signaling in C. elegans
(A) Comparison of NHR signaling in nematodes and mammals. In nematodes, oxidation or epimerization in position 3, oxidation in position 7, and side-chain
oxidation produces ligands of DAF-12, whereas similar modification of the steroid skeleton in mammals produces bile acids that serve as ligands of farnesoid X
receptor (FXR) (Russell, 2003) and possibly LXR (Theofilopoulos et al., 2013). Colors are used to highlight the functions of known enzymes in this pathway,
whereas enzymes introducing the structural features highlighted in gray have not been described.
(B) Biosynthesis model for DAF-12 ligands regulating development and lifespan. Enzymes in the XXX cells downstream of insulin and TGF-b signaling produce
small quantities of DAF-12 ligands, which trigger additional biosynthesis of DAF-12 ligands via upregulation of DAF-9 expression in the hypodermis, dependent
on intestinally expressed DAF-36 and possibly other tissues. Although DAF-9 has been assumed to act directly upstream of DAF-12, our results suggest that
DAF-9 may act on a variety of different substrates, including both 3-keto and 3-hydroxy sterols. Ligand biosynthesis is additionally regulated by STRM-1 and
feedback through DAF-12. The lifespan-increasing effects of DAF-12 ligands depend on germ cell removal.
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lated NHRs in higher animals. In contrast to earlier work that
proposed (primarily based on screening candidate structures)
D4-DA andD7-DA as endogenous DAF-12 ligands, our approach
revealed D1,7-DA as the most abundant ligand in WT worms, in
addition to smaller amounts of D7-DA and 3a-OH-D7-DA.
Steroids featuring a D1-double bond have been described
from very few natural sources (Wang et al., 2009a), although it
is well known that introduction of D1-unsaturation in natural
3-keto sterols (e.g., testosterone) can have pronounced effects
on their activities (Counsell and Klimstra, 1962). Analyses of
X-ray structures of the DAF-12 ligand binding domain com-
plexed with DAs have demonstrated that small structural
changes in the A andB rings of the bound steroid have significant
effects on the ligand’s affinity to DAF-12 (Wang et al., 2009b; Zhi
et al., 2012), suggesting that specific modifications in the steroid
A ring may serve to fine-tune DAF-12 transcriptional regulation.
Identification of the enzyme(s) introducing the D1-double bond
will play an important role in elucidating functional differences
between D1,7-DA and D7-DA and may motivate reanalysis of
mammalian metabolomes for the presence of endogenous D1-
steroids. The additional identification of the 3a-OH-D7-DA cre-
ates a striking parallel tomammalian bile acidmetabolism, which
predominantly produces sterols with 3a configuration (Figure 6A)
(Russell, 2003). Given its stereoselective biosynthesis by an80 Cell Metabolism 19, 73–83, January 7, 2014 ª2014 Elsevier Inc.as-of-yet unknown enzyme, it is likely that 3a-OH-D7-DA serves
specific functions in DAF-12 signaling. Notably, 3b-OH-D7-DA,
which was absent in WT worms but accumulated in hsd-1;
daf-22 and daf-12 mutant worms, is much less active in both
the in vivo and in vitro assays. However, it should be noted
that both the transcriptional activation assay in mammalian cell
culture (Figure 5B) and the AlphaScreen assay (Figure 5D) have
limited cogency for judging the relative potency of different
DAF-12 ligands in vivo, as both assays depend on recruitment
of mammalian coactivators, such as SRC-1, whereas in vivo
function of DAF-12 is thought to involve ligand-dependent
dissociation of the endogenous C. elegans corepressor DIN-1
followed by binding of as-of-yet unidentified coactivators (Lude-
wig et al., 2004). The identification of multiple endogenous small-
molecule regulators of DAF-12 in this study will accelerate the
pursuit of currently elusive DAF-12 interactors and other compo-
nents of DAF-12-dependent dauer and lifespan regulation.
Whereas it is well established that DAF-12 ligands are ulti-
mately derived from dietary cholesterol, identification of D1,7-
DA and 3a-OH-D7-DA and the absence of D4-DA necessitates
revision of DAF-12 ligand biosynthesis models (Figures 1B
and 6A). Our results indicate that DAF-36 as well as HSD-1
participate in the biosynthesis of D7-DA and possibly D1,7-DA,
whereas previously, HSD-1 had been assumed to function in
D4-DA biosynthesis. The finding that mutation of dhs-16 affects
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Endogenous Ligands of C. elegans DAF-12D7-DA much more strongly than D1,7-DA production suggests
that introduction of the 3-keto moiety in D1,7-DA may involve
a different enzyme. Therefore, it appears that different DAF-
12 ligands are produced via partially separate biosynthetic
pathways, which is also supported by the finding that in
strm-1 mutants, D7-DA production is increased to an extent
much greater than that of D1,7-DA. Taken together, our identifi-
cation of D1,7-DA, 3a-OH-D7-DA, and D0-DA indicates that
several DAF-12 ligand biosynthetic enzymes remain to be
identified.
C. elegans offers a unique opportunity to study the role of tis-
sue-specific NHR ligand biosynthesis for endocrine signaling in a
simple model system. Expression of DAF-12 ligand biosynthetic
enzymes is thought to be controlled by insulin/IGF and TGF-b
signaling; thus, ligand biosynthesis connects DAF-12 transcrip-
tional regulation with these two highly conserved pathways (Fig-
ure 1A) (Wollam et al., 2012). The biosynthesis ofmultiple DAF-12
ligands via partially separate pathways suggests that different
ligands may serve different functions (Arda et al., 2010). Notably,
a recent study showed that DAF-12 ligands or ligand derivatives
produced in the neuroendocrine XXX cells function as signaling
molecules that trigger abundant additional ligand biosynthesis
in the hypodermis, locking in organism-wide commitment to
reproductive development (Figure 6B) (Gerisch and Antebi,
2004; Schaedel et al., 2012). Since the XXX cells are the primary
sites of HSD-1 expression (Dumas et al., 2010; Patel et al., 2008),
our finding that HSD-1 may contribute to D7-DA biosynthesis
supports a model in which XXX-produced D7-DA (or derived
3a-OH-D7-DA) triggers biosynthesis of large quantities of addi-
tional D7-DA and D1,7-DA via daf-36, dhs-16, and hypodermal
daf-9 (Figure 6B). Ultimately, the elucidation of DAF-12 ligand
biosynthetic pathways will require combining comparative
metabolomics with tissue-specific manipulation of candidate
genes. This will entail consideration of life-stage-specific
aspects of ligand functions and biosynthesis, especially with
regard to the intriguing role of DAF-12 ligands for adult longevity,
which depends on additional signaling from the germline
(Figure 6B) (Yamawaki et al., 2010).
DAF-12 ligands regulate adult longevity by activating
microRNA targets that ultimately increase conserved DAF-16/
FOXO transcriptional activity, thereby extending lifespan (Shen
et al., 2012). Although the enzymes in DA biosynthesis are not
strict orthologs of functionally corresponding enzymes in
mammalian bile-acid biosynthesis, the striking similarities of
steroidal NHR ligand biosynthetic pathways in nematodes and
humans demonstrate the utility of C. elegans as a model organ-
ism for endocrine signaling (Figure 6A). Further functional
characterization of the identified DAF-12 ligands will advance
understanding of the roles of ligand-dependent NHRs in organ-
ism-wide coordination of metazoan development and aging. In
addition, our study shows that NMR-based comparative metab-
olomics can provide detailed insight into metazoan small-mole-
cule signaling pathways and that this approach can reveal
signaling molecules and biosynthetic functions not suspected
based on classical genetics and biochemical approaches.
Finally, the DAF-12 ligands discovered here will yield important
insights to combat parasitic infections, as parasitic nematodes
use the DAF-12/DA signaling mechanism to regulate emergence
from the infective stage (Ogawa et al., 2009; Wang et al., 2009b).CEXPERIMENTAL PROCEDURES
C. elegans Strains and Maintenance
Nematode stocksweremaintained on nematode growthmedium (NGM) plates
madewithBactoAgar (BDBiosciences) and seededwithbacteria (E. coliOP50)
at 20C (http://www.wormbook.org/). C. elegans strains: WT (N2, Bristol),
daf-22(m130), daf-22(ok693), daf-9(dh6), daf-9(dh6);daf-12(rh411rh61),
hsd-1(mg345), hsd-1(mg433), hsd-1(mg433);daf-22(ok693), daf-36(k114),
daf-36(k114);daf-22(ok693), dhs-16(tm1890), dhs-16(tm1890);daf-22(m130),
strm-1(tm1781), glp-1(e2141), glp-1(e2141);daf-36(k114), daf-12(rh411rh61).
Compound mutants were constructed using standard techniques. Worms
were grown at 20C for at least two generations under replete conditions prior
to liquid cultures.
Liquid Cultures
Worms from 4 10 cm NGM agar plates were washed using M9 medium into a
100 ml S complete medium preculture, where they were grown for 4 days at
22C on a rotary shaker. Concentrated bacteria from 1 l of E. coliOP50 culture
was added as food at days 1 and 3. On day 4, the preculture was divided
equally into 16 500ml Erlenmeyer flasks, each containing 100ml of S complete
medium. The resulting 16 cultures were grown for another 5 days at 22C on a
rotary shaker and continuously fed with concentrated bacteria, avoiding
depletion of bacterial food at all times. The cultures were harvested on day 5
and centrifuged to separate supernatant media and worm pellets. At harvest,
liquid cultures contained approximately 50%–70% L1–L3 worms. In liquid cul-
tures grown for 5 days at 22C (at time of harvest), we observed 15%–20%
dauers for N2, 2%–5% for daf-22, and none for daf-9;daf-12 and daf-12
mutants. daf-36, dhs-16, and hsd-1 mutant worm cultures show 70%–95%
dauers, whereas we observed less than 10% dauers in daf-36;daf-22, dhs-
16;daf-22, and hsd-1;daf-22 double-mutant cultures. The worm pellets were
stored at 20C until needed. Each 100 ml liquid culture yielded 2–3 ml of
worm pellet, all of which was used for one replicate of metabolite extraction
and analysis. At least three independent sets of cultures for daf-22 and N2,
and two for each of the steroid metabolism mutants, were used.
ForDAanalysis of synchronized cultures, gravid adults from54010cmplates
were washed with M9 buffer and treated with alkaline hypochlorite solution to
isolate eggs. Eggs were washed twice with M9 buffer and hatched in fresh M9
for 24 hr. The synchronized L1 larvaewere divided into two sets and transferred
to S completemedium containing OP50. One set was allowed to grow for 25 hr
at 20C and 220 rpm, at which point the cultures were predominantly a 1:1
mixture of L2 and L3 larvae. A second set was grown for 48 hr and harvested
when the culture contained a 9:1 mixture of L4 and young adults (YA). At the
end of the specified growth period, the cultures were centrifuged at 4C and
the worm pellets stored at 20C until processing for further analysis.
Preparation of Metabolome Extracts
The frozen worm pellets were added to precooled (78C) methanol (200 ml
for each liquid culture and 20 ml for each staged culture) in a Waring blender
and blended until no chunks remained. Methanol was evaporated in vacuo
at 0C –20C, and the residue was resuspended in water (300 ml for liquid cul-
tures and 25 ml for staged cultures). The resulting suspension was then lyoph-
ilized, and the residue was crushed to a fine powder using a mortar and pestle
over 8 g of granular sodium chloride. The powder was then extracted twice
with a 9:1 ethyl acetate:ethanol mixture (250 ml for samples obtained from
liquid cultures and 25 ml for samples from staged liquid cultures) over 12 hr.
The resulting suspension was filtered, and the filtrate was evaporated in vacuo
at room temperature to produce the worm pellet metabolome extract used for
chromatographic separations and analysis. For details, please see Supple-
mental Experimental Procedures.
NMR Spectroscopic Instrumentation and Analysis
NMR spectra were recorded on a Varian 900 MHz NMR Spectrometer equip-
ped with a 5 mm 1H (13C/15N) cryogenic probe, a Varian Inova 600 MHz NMR
Spectrometer equipped with an HCN indirect detection probe, and a Varian
Inova 500 MHz NMR Spectrometer equipped with a DBG broadband probe.
Each spectrum was manually phased, baseline corrected, and calibrated
to solvent peaks (CHCl3 singlet at 7.26 ppm; CHD2OD pseudoquintet at
3.31 ppm). Nongradient phase-cycled double-quantum filtered correlationell Metabolism 19, 73–83, January 7, 2014 ª2014 Elsevier Inc. 81
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Endogenous Ligands of C. elegans DAF-12spectroscopy (DQF-COSY) spectra were acquired using the following param-
eters: 0.8 s acquisition time, 500–900 complex increments, 16–64 scans per
increment. DQF-COSY spectra were zero filled to 8,192–16,384 3 4,096,
and a cosine bell-shaped window function was applied in both dimensions
before Fourier transformation. NMR spectra were processed using Varian
VNMR, MestreLab’s MestReC, and Mnova software packages. Dynamic
range of the resulting spectra ranged from 300:1 to 500:1. For example,
coupling constants could be determined for characteristic steroidal cross-
peaks from DQF-COSY spectra containing as little as 5 mg D1,7-DA in a
2.5 mg metabolome fraction.
daf-9(dh6) Dauer Rescue Assay
Plate-based assay: metabolome fractions were resuspended in ethanol,
mixed with 40 ml of 53 concentrated OP50 bacteria (from an overnight culture
in lysogeny broth [LB] media), and plated on 3 cm plates containing 3 ml of
NGM agar without added cholesterol. For rescue, 100 eggs from a 4–8 hr
egg lay were transferred onto the bacterial lawn and scored for dauer arrest
at 27C after 60 hr. For rescue experiments with synthetic steroids (0.1–
500 nM tested), 10 ml compounds in ethanol (or ethanol alone) were mixed
with 40 ml 53 concentrated OP50 bacteria and plated. Final concentrations
include the total volume of agar (3 ml). We used 100 nM D7-DA as a positive
control. Additional rescue assays in liquid cultures were also carried out
(for details, please refer to Supplemental Experimental Procedures). Data
obtained from both plate-based and liquid culture assays are comparable.
Figures in this paper are based on results from the plate-based assay.
Luciferase Assay for DAF-12 Transcriptional Activation
Luciferase assays to determine transcriptional activation of DAF-12 were per-
formed as described earlier (Bethke et al., 2009). Briefly, HEK293T cells were
seeded and transfected in 96-well plates with (per well) 30 ng transcription
factor vector, 30 ng of GFP expression vector, 30 ng of luciferase reporter,
and 5 ng b-galactosidase expression vector using the calcium phosphate
precipitate method. Ethanol or ethanol solutions of ligands (synthetic DAs,
1–3,125 nM tested and metabolome fractions) were added 8 hr after transfec-
tion, and the luciferase and b-galactosidase activities were measured by a
Synergy 2 BioTek LC Luminometer 16 hr after compound addition. We used
100 nM D7-DA as a positive control. Data were processed using GEN5 soft-
ware. Individual fractions were dried in vacuo and resuspended in 500 ml
EtOH. We added 1 ml per 100 ml of media solution to each well.
AlphaScreen Assay for Direct Binding of DAF-12 Ligand Candidates
Direct binding of ligand candidates to DAF-12 was assessed using the
AlphaScreen assay kit (PerkinElmer) as described previously (Motola et al.,
2006). Also see Supplemental Experimental Procedures.
Statistical Analyses
All data, except for Figure 5D, are presented as mean ± SD. Data in Figure 5D
are presented as mean ± SEM.
Nomenclature of DAF-12 Ligands
The IUPAC names for dafachronic acids as well as semirational constructs,
such as 3a-hydroxy-D7-dafachronic acid, are cumbersome, unlikely to be
used consistently, and thus pose problems for text search algorithms and
database curation. Therefore, we have obtained, for each of the identified
dafachronic acid derivatives, unique small-molecule identifiers (SMIDs), from
the C. elegans Small Molecule Identifier Database (SMID DB, http://smid-db.
org/), an affiliate of Wormbase. SMIDs can be obtained for all newly identified
C. elegans metabolites upon request. Thus, D1,7-DA, D7-DA, 3a-OH-D7-DA,
D4-DA, D0-DA, and 3b-OH-D7-DA have been named dafa#1, dafa#2, dafa#3,
dafa#4, dafa#5, and dafa#6, respectively, as shown in Figure 4. To ensure
effective curation, SMID DB recommends that the dafachronic acids be
referred to by their respective SMIDs in subsequent publications.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
three figures, and three tables and can be found with this article online at
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